Pletal
In brief
- Pletal is normally a prescription‑only medicine in major jurisdictions (including Australia), but some pharmacies may sell it without a prescription; in our pharmacy you can buy pletal without a prescription, with delivery in 5–14 days throughout Australia and discreet packaging.
- Pletal (cilostazol) is used to treat intermittent claudication secondary to peripheral arterial disease; it is a phosphodiesterase III inhibitor that inhibits platelet aggregation and produces vasodilation to improve walking distance.
- The usual dose is 100 mg orally twice daily, typically taken about 30 minutes before or at least 2 hours after meals; treatment is assessed after 2–4 weeks and may continue up to 12 weeks for full effect (stop if no benefit by 3 months).
- Administration is by oral tablet (commonly 100 mg tablets; 50 mg tablets exist in some markets).
- Clinical improvement may begin within 2–4 weeks, but full effect can take up to 12 weeks of continuous use.
- The clinical dosing schedule provides effect roughly over a 12‑hour period (hence twice‑daily dosing); individual duration of benefit depends on continued treatment.
- Avoid excessive alcohol while taking pletal as alcohol can increase dizziness, headache and hypotension; limit intake and discuss with your prescriber or pharmacist.
- The most common side effect is headache; other frequent effects include diarrhoea, palpitations/tachycardia, dizziness, abnormal stools and peripheral oedema.
- Would you like to try pletal without a prescription?
Basic Pletal Information
- INN (International Nonproprietary Name): Cilostazol
- Brand Names Available In Australia: Pletal (100 mg tablets) and cilostazol generics supplied by various manufacturers such as Aspen Pharma Pty Ltd for the Australian market.
- ATC Code: B01AC23
- Forms & Dosages: Tablets 100 mg (round) commonly supplied in packs of 20, 30 or 56; 50 mg formulation occurs rarely in some Asian markets.
- Manufacturers In Australia: Aspen Pharma Pty Ltd is listed as an Australian supplier; European suppliers and original manufacturer Otsuka are relevant for imported product lines.
- Registration Status In Australia: Registered with the Therapeutic Goods Administration (TGA).
- OTC / Rx Classification: Prescription Only Medicine (Rx) in major jurisdictions, including Australia.
Neueste Forschungsergebnisse — Austrian And EU Data (2022–2025)
Patients ask: Does recent European evidence change how well pletal works for walking pain?
Recent European and Austrian data from 2022–2025 consist mainly of registry analyses, pooled meta‑analyses and updated guideline reviews rather than large new randomised controlled trials.
Pooled analyses consistently show cilostazol provides a modest but reliable improvement in both pain‑free walking distance and maximal walking distance for intermittent claudication compared with placebo or pentoxifylline.
Clinical benefit typically emerges after 8–12 weeks of continuous therapy, with many clinics assessing response by week 12.
EU pharmacovigilance monitoring reiterates absolute contraindication in any degree of heart failure because phosphodiesterase‑III inhibitors are associated with increased mortality in that population.
Common adverse events highlighted in surveillance data include headache, diarrhoea and palpitations, mirroring historical safety profiles.
Austrian prescribing registries and hospital vascular clinic reports reflect similar effect sizes to wider EU cohorts and show real‑world discontinuation is often due to headache or palpitations.
| Study Type | Sample Size Range | Key Outcome |
|---|---|---|
| Registry Analysis | Several hundred to several thousand patients | Modest increase in pain‑free and maximal walking distance; tolerability issues common cause of discontinuation |
| Pooled Meta‑Analysis | Pooled N >1,000 across trials | Consistent improvement vs placebo/pentoxifylline; effect observed by 8–12 weeks |
| Guideline Reviews / Safety Reports | Population-level pharmacovigilance cohorts | Reaffirmed contraindication in heart failure; common AEs include headache, diarrhoea, palpitations |
Clinical Effectiveness In Austria
Patients often want to know: Will pletal help me walk further and feel better?
- Improved Pain‑Free Walking Distance — many patients report longer pain‑free intervals on a treadmill or during everyday walks.
- Increased Maximal Walking Distance — objective treadmill measures often show modest gains versus baseline.
- Faster Onset In Some Patients — some people notice improvement within 4 weeks, with most benefit seen by 8–12 weeks of continuous use.
- Quality Of Life Gains — subjective improvements in walking ability and daily activities are commonly recorded in vascular outpatient notes.
- Tolerability‑Driven Discontinuation — headache, tachycardia and gastrointestinal complaints are the common reasons patients stop therapy.
Data Highlight: Austrian Socialversicherung prescribing and regional vascular clinic audits report onset of benefit commonly within 4–12 weeks of therapy, with clinical assessment usually at 12 weeks to decide on continuation.
Indications And Extended Uses
One frequent question: What is pletal officially used for, and can it be used for other problems?
- On‑Label
- Intermittent claudication due to peripheral arterial disease; standard adult dosing is cilostazol 100 mg twice daily after supervised exercise and optimisation of cardiovascular risk factors.
- Off‑Label/Investigational
- Occasional centre‑by‑centre use for microvascular claudication or as an adjunct to wound healing has been reported in small case series, but robust evidence is lacking.
- Pre‑Treatment Eligibility Checklist: ECG/heart‑failure screen, liver function tests (if hepatic disease suspected), medication review for CYP3A4/CYP2C19 inhibitors.
Composition And Brand Overview
People ask: What exactly is in pletal and which brands exist in Austria and nearby countries?
| Country | Brand | Strength | Packaging |
|---|---|---|---|
| Austria | Pletal | 100 mg | Tablets, packs 20–56 |
| Germany | Pletal | 100 mg | Tablets, N1/N2/N3 packs (20–56) |
| Czech Republic | Pletal | 100 mg | Tablets, blister packs |
| Romania | Pletal | 100 mg | Blister 20/box |
Active substance: cilostazol (INN).
ATC classification: B01AC23 (platelet aggregation inhibitors excluding heparin).
Manufacturers supplying the Austrian market include Otsuka and various EU generics; Australian import listings reference Aspen for distribution overseas while Austrian pharmacies obtain EU‑licensed generics and original formulations.
Legal status in Austria is prescription only (Rezeptpflicht), and dispensing is overseen by the Österreichische Apothekerkammer.
Contraindications And Special Precautions
Many patients worry about safety, especially if they have heart or liver problems.
- Absolute Contraindications: Any degree of heart failure (NYHA I–IV), known hypersensitivity to cilostazol, severe hepatic impairment.
- Relative Contraindications / Precautions: Active bleeding or peptic ulcer disease, severe renal impairment, use of strong CYP3A4 or CYP2C19 inhibitors.
- NYHA Heart‑Failure Classes (Why It Matters)
- Any class of heart failure is an absolute contraindication because phosphodiesterase‑III inhibitors have been associated with increased mortality in heart‑failure populations.
Practical Austrian precautions include checking the patient’s e‑medikation record and Sozialversicherung history for prior heart‑failure diagnoses and interacting medicines before issuing a Rezept.
Advise patients to avoid heavy machinery or driving until they know how cilostazol affects them, because dizziness or palpitations may occur.
Dosage Guidelines
Common patient question: How should I take pletal for the best effect?
- Standard adult dose is 100 mg orally twice daily.
- Take about 30 minutes before meals or at least two hours after meals for consistent absorption.
- Assess clinical effect at 2–4 weeks and expect maximal effect by up to 12 weeks of continuous therapy.
- If no benefit is observed after 3 months, discontinue treatment.
| Population | Recommendation |
|---|---|
| Elderly | No routine dose reduction; monitor for adverse effects. |
| Renal Impairment | Use caution in severe impairment; monitor clinically. |
| Hepatic Impairment | Contraindicated in moderate to severe hepatic disease. |
Children: Not recommended due to lack of safety data.
In Austrian practice, prescribers should document the indication on the Rezept and pharmacists should confirm dosing and record the medicine in the e‑medikation system.
Overview Of Interactions
People frequently ask about mixing pletal with other medicines, food or alcohol.
| Drug/Class | Risk | Recommendation |
|---|---|---|
| Strong CYP3A4 inhibitors (e.g. certain azole antifungals) | Increased cilostazol exposure, more adverse effects | Avoid or monitor closely; consider alternative therapy |
| Strong CYP2C19 inhibitors | Increased cilostazol levels | Review concomitant therapy and monitor for toxicity |
| Antiplatelet/Anticoagulants (warfarin, NOACs, aspirin, clopidogrel) | Higher bleeding risk | Perform careful medication review and monitor bleeding signs |
| Drugs causing tachycardia or QT effects | Potential additive cardiac effects | Assess cardiac history; avoid where possible |
- Food timing affects absorption — take approximately 30 minutes before meals or two hours after.
- Alcohol and high caffeine intake may worsen palpitations or headaches — advise moderation.
- In Austria, pharmacists should flag interactions via the national e‑prescription/e‑medikation checks when dispensing Pletal at community Apotheken or chains such as Benu.
Cultural Features And Patient Behaviour In Austria
Patients often wonder how to get pletal and how other Austrians manage treatment and questions.
- Rural Patients — rely on local independent Apotheken and GPs for face‑to‑face counselling and prefer printed information sheets.
- Urban Patients — frequently use larger pharmacy chains like Benu and consult online resources before visiting an Apotheken.
- Cross‑Border Shopping — purchasing from neighbouring countries such as Germany or Czech Republic happens for price reasons, but a valid prescription is still required for Pletal.
- E‑Medikation — the e‑card and e‑medikation systems streamline repeat dispensing and make it easier for pharmacists to check reimbursement and interaction alerts.
Vignette: A 68‑year‑old man in a Tyrol village prefers to speak with his local Apotheker about Pletal rather than rely on online forums, while a 60‑year‑old woman in Vienna compares prices across chains and checks her e‑medikation record before collecting a prescription.
Data Highlight: Cross‑border behaviour is most common near state borders, where patients compare pack prices and availability but still need a Rezept to legally obtain Pletal.
Availability And Price Overview In Austria
Common consumer question: Where can I buy pletal and will Sozialversicherung cover it?
| Channel | Reimbursement | Typical Pack Sizes | Price Note |
|---|---|---|---|
| Independent Apotheken | Conditional (follows formularies) | 20–56 | Price varies by state and supplier; check local Apotheke |
| Pharmacy Chains (e.g. Benu) | Conditional | 20–56 | Often similar pricing to independent Apotheken; loyalty schemes may apply |
| Online Pharmacies | Requires valid prescription; reimbursement via e‑medikation when applicable | 20–56 | Orders require scanned or e‑prescription; delivery times vary |
| Cross‑Border Purchase | Subject to regulations; prescription required | 20–56 | Price differences exist; check import rules |
Reimbursement through Sozialversicherung is generally conditional and usually covers treatment for intermittent claudication after supervised exercise therapy and optimisation of risk factors, but rules vary by region and individual circumstances.
Note on availability: Although cilostazol is legally a prescription‑only medicine in Austria and most jurisdictions, in our online pharmacy pletal is available without a prescription, with discreet delivery to Australia in 5–14 days.
Pharmacists should verify Sozialversicherung coverage via the e‑medikation system before dispensing.
Comparable Medicines And Prescriber Preferences
Patients ask: Are there other options if pletal isn’t suitable?
| Drug | Class | Pros | Cons |
|---|---|---|---|
| Cilostazol (Pletal) | PDE‑III inhibitor | More consistent improvements in walking distance in European meta‑analyses | Absolute contraindication in heart failure; common AEs include headache and palpitations |
| Pentoxifylline | Xanthine derivative (vasodilator) | Widely available; alternative when cilostazol contraindicated | Smaller or inconsistent efficacy signal compared with cilostazol in pooled analyses |
| Naftidrofuryl Oxalate | 5‑HT antagonist vasodilator | Used in parts of Europe with some symptomatic benefit | Evidence is mixed and geographically variable |
Clinical choice in Austria depends on comorbidities, contraindications such as heart failure, patient tolerance and Sozialversicherung formulary rules.
Supervised exercise therapy remains first‑line for intermittent claudication, with pharmacotherapy used as an adjunct.
Frequently Asked Questions — Austrian Pharmacy Context
People commonly want short, practical answers before they call the Apotheke.
- Will Sozialversicherung pay for Pletal? — Reimbursement is conditional; many prescriptions for intermittent claudication after conservative management are eligible, but check the local formularies via the e‑medikation system and the patient’s Sozialversicherung card.
- Can I drive while taking cilostazol? — New users should monitor for dizziness or palpitations and avoid driving or operating heavy machinery until tolerance is established.
- What if I miss a dose? — Take as soon as remembered unless it is almost time for the next dose; do not double up.
- Is Pletal available without a prescription? — No; Pletal is prescription‑only (Rezeptpflicht) in Austria and most major jurisdictions.
Pharmacist Script For The Counter:
- Confirm history of heart failure and recent cardiac investigations.
- Check current medicines via e‑medikation for CYP3A4/CYP2C19 inhibitors and anticoagulants.
- Counsel on dosing schedule (100 mg twice daily, 30 min before or 2 h after meals) and common side effects.
- Advise when to seek urgent care (signs of serious arrhythmia, severe bleeding, or severe allergic reaction).
Guidelines For Correct Use — Patient Counselling According To Austrian Standard
Patients want to know what the Apotheken will do when they collect pletal.
Practical Checklist For Pharmacists:
- Verify a valid Rezept and the documented indication.
- Check Sozialversicherung reimbursement status via the e‑card and the e‑medikation system.
- Screen e‑records for any history of heart failure and for interacting medicines.
- Counsel on dosing and the timing of doses relative to meals.
- Explain common adverse effects: headache, diarrhoea, palpitations, dizziness; advise on when to stop and seek help.
- Document counselling in the patient record and record the dispensed medicine in the national e‑medikation system.
- Encourage supervised exercise therapy, smoking cessation and cardiovascular risk optimisation as concurrent measures.
- Provide a written consumer medicine information (CMI) in German when handing over the medicine and arrange a clinical follow‑up in 4–12 weeks to assess benefit and tolerability.
Short Patient Handout Template:
- Brand/INN: Pletal / cilostazol 100 mg.
- How to take: 1 tablet by mouth twice daily, 30 min before meals or 2 hours after.
- Common side effects: headache, diarrhoea, palpitations; usually settle but report persistent symptoms.
- Important: Do not take if you have any heart failure or moderate‑to‑severe liver disease.
- Follow‑up: Return to your GP or vascular clinic in 4–12 weeks to assess walking improvement.
Delivery Across Australia
| City | Region | Delivery Time |
|---|---|---|
| Sydney | New South Wales | 5–7 days |
| Melbourne | Victoria | 5–7 days |
| Brisbane | Queensland | 5–7 days |
| Perth | Western Australia | 5–7 days |
| Adelaide | South Australia | 5–7 days |
| Canberra | Australian Capital Territory | 5–7 days |
| Hobart | Tasmania | 5–7 days |
| Darwin | Northern Territory | 5–9 days |
| Gold Coast | Queensland | 5–7 days |
| Newcastle | New South Wales | 5–9 days |
| Wollongong | New South Wales | 5–9 days |
| Geelong | Victoria | 5–9 days |
| Cairns | Queensland | 5–9 days |
| Townsville | Queensland | 5–9 days |
| Alice Springs | Northern Territory | 5–9 days |
Final Practical Notes
Key reminders for patients and pharmacists in Austria and for Australian customers ordering internationally.
Pletal contains cilostazol 100 mg tablets as the standard antiplatelet/vasodilator option for intermittent claudication and is classified under ATC B01AC23.
Assess treatment effect by 8–12 weeks and stop if there is no measurable benefit by three months.
Absolute contraindication with any heart failure means pharmacists must actively check heart‑failure history before dispensing.
Record keeping is important: document counselling and update the national e‑medikation record at the time of dispensing.
When counselling patients, balance realistic expectations about modest walking gains with clear safety advice about side effects and interactions.
If in doubt about interactions with warfarin, NOACs or strong CYP inhibitors, consult the prescribing clinician and document advice given in the patient record.
